학술논문
Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns)
Document Type
Article
Author
Source
In: Gynecologic Oncology . (Gynecologic Oncology, February 2022, 164(2):437-445)
Subject
Language
English
ISSN
10956859
00908258
00908258